@conference{01eb2bf343864d499bc8a2e30181b503,
title = "52-Week Efficacy and Safety Results from SPIRIT-P1: A Phase 3 Study of Ixekizumab in Patients with Active Psoriatic Arthritis{\textquoteright}. Canadian Rheumatology Association (CRA), Ottowa, Feb 2017.",
author = "Philip Mease and et.al.",
note = "La SCR facilite les rencontres et soutient l{\'e}ducation et la recherche gr{\^a}ce {\`a} une s{\'e}rie dinitiatives, notamment la publication du Journal de la Soci{\'e}t{\'e} canadienne de rhumatologie (JSCR) et lacquisition du Journal of Rheumatology (JRheum).; Canadian Rheumatology Association (CRA) ; Conference date: 01-02-2017",
year = "2017",
month = feb,
language = "American English",
}